Sanofi aims to grow Genzyme unit with new drugs and acquisitions
September 11, 2014 at 01:00 AM EDT
PARIS, Sept 11 (Reuters) - Sanofi rare disease unit Genzyme hopes to become a leader in the multiple sclerosis (MS) field with the help of new products developed in-house but also through acquisitions, senior Genzyme executives told Reuters.